Published in Medical Letter on the CDC and FDA, August 15th, 2004
The Consortium will conduct five studies of IPTi in Africa, to be coordinated by the newly established Secretariat in Barcelona. The grants are part of a US$28 million commitment to support the Consortium announced by the Gates Foundation in September 2003.
IPTi is a potential way of using existing antimalarial drugs to protect infants from the worst effects of the disease. Under this approach, infants receive an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA